Supply Chain

Why companies must tighten their supply chains in light of Chinese anti-espionage laws and other regulatory clampdowns.

How pharmaceutical companies are aligning their sustainability goals with the complexities of the modern supply chain

Following on from deaths attributed to contaminated medicines, here’s how the US Pharmacopeia is promoting testing for DEG and EG.

As incidents of DEG poisoning continue to occur, the IPEC Federation issues a call for companies not to be complacent when it comes to supply chains.

As the Sunshine State looks to import medicines to lower costs for Floridians, what of ongoing shortages for Canadians?

From automation to integration, there is huge room for improvement in supply chain management systems for cell and gene therapies

Experts from the Access to Medicine Foundation discuss how to reduce the risk of antimicrobial resistance (AMR) in antibiotic manufacturing.

A deep dive into the dangers of fentanyl entering the US supply chain – and the importance of the Drug Supply Chain Security Act

How the European Commission has struck deals to secure manufacturing capacity for future emergencies.

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.